Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at volrustomig and chemotherapy for non small cell lung cancer (eVOLVE-Lung 02)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers

Status:

Open

Phase:

Phase 3

Details

This trial is comparing volrustomig (MEDI5752) and chemotherapy with pembrolizumab and chemotherapy. It is for people with non small cell lung cancer that has spread to another part of the body.

You pronounce volrustomig as vole-rust-oh-mig.

Recruitment start: 11 December 2023

Recruitment end: 14 December 2026

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Tom Newsom-Davies

Supported by

AstraZeneca

Last reviewed: 27 February 2025

CRUK internal database number: 19602

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.